Technology & Software Global On demand · 24-48h

Global Cell Characterization Tests Market Strategic Research Report

Name: Global Cell Characterization Tests Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Cell Characterization Tests Market Strategic Research…

$3,500 USD

Strategic Research Report

Global Cell Characterization Tests Market

$1.69B2025

4.7%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Short Tandem Repeat (STR) Analysis, Single Nucleotide Polymorphism (SNP) Analysis, Others

By Application: Microbial Contamination, Cell Line Identity, Genetic Stability, Virus Testing, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories, Inc., Laboratory Corporation of America Holdings, Microsynth AG, NorthGene Limited (Biofortuna Limited), Perfectus Biomed Limited, Promega Corporation, SGS SA, Sigma-Aldrich Co. LLC. (Merck KGaA), Thermo Fisher Scientific, Inc.

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 105 pages

Market size 2025

$1.69B

Billion USD

Forecast CAGR

4.7%

2025-2032

Forecast 2032

$2.3B

Projected

Regions

Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Cell Characterization Tests market size is predicted to grow from US$ 1,693 million in 2025 to US$ 2,317 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplex polymerase chain reaction (PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.

The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.

This report presents a comprehensive overview of the global Cell Characterization Tests market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Short Tandem Repeat (STR) Analysis
Single Nucleotide Polymorphism (SNP) Analysis
Others

Segment by Application

Microbial Contamination
Cell Line Identity
Genetic Stability
Virus Testing
Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cell Characterization Tests market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Microbial Contamination, Cell Line Identity, Genetic Stability evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cell Characterization Tests Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 4.7%

Regional growth momentum

Market share by segment

Key metrics

Base value

$1.69B

2025

Forecast

$2.3B

2032

CAGR

4.7%

2025–2032

Regions

global

Key companies

Bio-Synthesis, Inc.Cell Line Genetics, Inc.Charles River LaboratoriesDNA Forensics Lab IndiaEurofins Genomics (Eurofins Scientific)GenomeScanIDEXX Laboratories, Inc.Laboratory Corporation of America Holdings

Segments covered in this report

By Type

Short Tandem Repeat (STR) AnalysisSingle Nucleotide Polymorphism (SNP) AnalysisOthers

By Application

Microbial ContaminationCell Line IdentityGenetic StabilityVirus TestingOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Short Tandem Repeat (STR) Analysis
3.1.3 Single Nucleotide Polymorphism (SNP) Analysis
3.1.4 Others
3.1.5 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Microbial Contamination
4.1.3 Cell Line Identity
4.1.4 Genetic Stability
4.1.5 Virus Testing
4.1.6 Others
4.1.7 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Bio-Synthesis, Inc.
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Cell Line Genetics, Inc.
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Charles River Laboratories
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 DNA Forensics Lab India
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Eurofins Genomics (Eurofins Scientific)
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 GenomeScan
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 IDEXX Laboratories, Inc.
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Laboratory Corporation of America Holdings
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Microsynth AG
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 NorthGene Limited (Biofortuna Limited)
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Perfectus Biomed Limited
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Promega Corporation
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 SGS SA
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Sigma-Aldrich Co. LLC. (Merck KGaA)
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Thermo Fisher Scientific, Inc.
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Cell Characterization Tests market?

The global Cell Characterization Tests market is estimated at US$ 1.69 billion in 2025 (base year) and is projected to reach US$ 2.32 billion by 2032.

What is the forecast CAGR for the Cell Characterization Tests market?

The market is expected to grow at a CAGR of 4.7% from 2026 to 2032, expanding from US$ 1.69 billion in 2025 to US$ 2.32 billion in 2032, roughly 1.4 times its base-year value.

What is Cell Characterization Tests?

What are the main segments of the Cell Characterization Tests market by type?

By type, the market is segmented into Short Tandem Repeat (STR) Analysis, Single Nucleotide Polymorphism (SNP) Analysis and Others.

Which applications drive demand in the Cell Characterization Tests market?

Key applications covered include Microbial Contamination, Cell Line Identity, Genetic Stability, Virus Testing and Others.

Who are the key players in the Cell Characterization Tests market?

Key players profiled include Bio-Synthesis, Cell Line Genetics, Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories and Laboratory Corporation of America Holdings, among 15 companies covered in total.

Which regions and countries are covered for Cell Characterization Tests?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What is driving growth in the Cell Characterization Tests market?

The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.

Who should buy the Cell Characterization Tests market report?

The report is intended for manufacturers and solution providers, distributors and end users in Microbial Contamination, Cell Line Identity and Genetic Stability, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cell Characterization Tests market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.